S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda

Cassava Sciences (SAVA) News Today

$19.64
-1.55 (-7.31%)
(As of 04/19/2024 ET)
SourceHeadline
MarketBeat logoCassava Sciences (NASDAQ:SAVA) Shares Down 6%
americanbankingnews.com - April 21 at 5:34 AM
msn.com logoHow Western food imports are fuelling obesity in Pacific nations
msn.com - April 20 at 8:05 PM
finance.yahoo.com logoCassava Sciences, Inc. (SAVA)
finance.yahoo.com - April 19 at 1:58 PM
marketbeat.com logoCassava Sciences (NASDAQ:SAVA) Trading 6.2% Higher
marketbeat.com - April 16 at 3:43 PM
marketbeat.com logoCassava Sciences (NASDAQ:SAVA) Sees Large Volume Increase
marketbeat.com - April 15 at 2:49 PM
globenewswire.com logoRedemption Date Announced for Warrants
globenewswire.com - April 15 at 9:20 AM
MarketBeat logoContrasting Cassava Sciences (NASDAQ:SAVA) & Nabriva Therapeutics (NASDAQ:NBRV)
americanbankingnews.com - April 15 at 1:44 AM
MarketBeat logoCassava Sciences (NASDAQ:SAVA) Shares Down 9%
americanbankingnews.com - April 14 at 4:42 AM
marketbeat.com logoCassava Sciences (NASDAQ:SAVA) Trading Down 9%
marketbeat.com - April 12 at 2:51 PM
MarketBeat logoCassava Sciences Sees Unusually Large Options Volume (NASDAQ:SAVA)
americanbankingnews.com - April 12 at 3:52 AM
marketbeat.com logoInvestors Purchase Large Volume of Call Options on Cassava Sciences (NASDAQ:SAVA)
marketbeat.com - April 11 at 4:50 PM
marketbeat.com logoCassava Sciences (NASDAQ:SAVA) Sees Strong Trading Volume
marketbeat.com - April 9 at 3:19 PM
marketbeat.com logoCassava Sciences (NASDAQ:SAVA) Trading Up 5.7%
marketbeat.com - April 8 at 1:46 PM
bizjournals.com logoAg nonprofit launched by Gates Foundation opens HQ in Cortex, grows to 30 employees
bizjournals.com - April 5 at 1:13 AM
msn.com logoStrong quake rocks Taiwan, tsunami warnings issued
msn.com - April 4 at 4:16 PM
ft.com logoCan Africa one day help feed the world’s growing population?
ft.com - April 3 at 3:22 AM
stockhouse.com logo24 HOUR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
stockhouse.com - April 2 at 5:22 PM
msn.com logoTracing science’s transformative impact on manifesto implementation
msn.com - April 2 at 10:59 AM
stockhouse.com logoFINAL SAVA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Cassava Sciences, Inc. Investors to Lead the Class Action Lawsuit!
stockhouse.com - April 1 at 4:59 AM
prnewswire.com logoSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
prnewswire.com - March 29 at 10:40 AM
finance.yahoo.com logoSAVA Apr 2024 17.000 put
finance.yahoo.com - March 29 at 10:02 AM
msn.com logoCassava: How Nutrition Professionals Assess Its Health Benefits, Nutrition Facts, And More
msn.com - March 28 at 8:39 PM
marketbeat.com logoSG Americas Securities LLC Sells 184,073 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA)
marketbeat.com - March 28 at 4:48 AM
markets.businessinsider.com logoSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava Sciences
markets.businessinsider.com - March 28 at 12:22 AM
prnewswire.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
prnewswire.com - March 27 at 2:05 PM
au.investing.com logoCassava Sciences' Alzheimer's drug continues Phase 3 trials
au.investing.com - March 26 at 7:02 AM
seekingalpha.com logoCassava Sciences: New Year, Same Game Of Smoke And Mirrors
seekingalpha.com - March 25 at 5:45 PM
markets.businessinsider.com logoDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
markets.businessinsider.com - March 25 at 12:45 PM
marketbeat.com logoCassava Sciences (NASDAQ:SAVA) Shares Gap Up to $19.81
marketbeat.com - March 25 at 11:54 AM
globenewswire.com logoCassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
globenewswire.com - March 25 at 9:13 AM
stockhouse.com logoDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
stockhouse.com - March 24 at 4:25 PM
stockhouse.com logoSHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Cassava Sciences, Inc. with Losses of $100,000 to Contact the Firm
stockhouse.com - March 23 at 11:43 PM
markets.businessinsider.com logoINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
markets.businessinsider.com - March 23 at 1:42 PM
marketbeat.com logoCassava Sciences (NASDAQ:SAVA) Shares Down 5.1%
marketbeat.com - March 22 at 5:06 PM
prnewswire.com logoSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
prnewswire.com - March 21 at 11:45 AM
stockhouse.com logoSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Cassava Sciences, Inc. with Losses of $100,000 to Contact the Firm
stockhouse.com - March 20 at 10:26 PM
ca.finance.yahoo.com logoSAVA Apr 2024 23.500 call
ca.finance.yahoo.com - March 20 at 4:23 AM
finance.yahoo.com logoSAVA Jun 2025 30.000 call
finance.yahoo.com - March 19 at 5:55 PM
finance.yahoo.com logoSAVA Jun 2025 10.000 put
finance.yahoo.com - March 19 at 5:55 PM
prnewswire.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
prnewswire.com - March 19 at 4:15 PM
ca.finance.yahoo.com logoSAVA Apr 2024 20.500 put
ca.finance.yahoo.com - March 18 at 4:24 AM
stockhouse.com logoROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
stockhouse.com - March 17 at 6:23 PM
seekingalpha.com logoCassava Sciences: Where Did All The Mild Alzheimer's Disease Patients Go?
seekingalpha.com - March 17 at 1:23 PM
finance.yahoo.com logoSAVA Mar 2024 19.500 put
finance.yahoo.com - March 16 at 10:24 AM
finance.yahoo.com logoSAVA Mar 2024 11.000 put
finance.yahoo.com - March 15 at 11:07 AM
finance.yahoo.com logoSAVA Mar 2024 17.500 call
finance.yahoo.com - March 14 at 10:10 PM
stockhouse.com logoUPCOMING SAVA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Cassava Sciences, Inc. Investors to Lead the Class Action Lawsuit!
stockhouse.com - March 14 at 7:09 AM
finance.yahoo.com logoSAVA Jan 2025 2.500 call
finance.yahoo.com - March 12 at 11:31 PM
markets.businessinsider.com logoONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
markets.businessinsider.com - March 12 at 11:05 PM
finance.yahoo.com logoSAVA Aug 2024 12.500 call
finance.yahoo.com - March 12 at 6:04 PM
Get Cassava Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter.

Double your money before lunch? (Ad)

Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.

This unique "Cut & Paste" technique has allowed researchers to reprogram viruses to wipe each other

SAVA Media Mentions By Week

SAVA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SAVA
News Sentiment

0.26

0.49

Average
Medical
News Sentiment

SAVA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SAVA Articles
This Week

7

5

SAVA Articles
Average Week

Get Cassava Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:SAVA) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners